Nassim Usman's Net Worth

$469 Thousand

Estimate Recalculated Sep 8, 2024 07:20PM EST

Who is Nassim Usman?

Nassim Usman does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include GYRE THERAPEUTICS, INC., Principia Biopharma Inc., and SIRNA THERAPEUTICS INC.

SEC CIK

Nassim Usman's CIK is 0001206872

Past Insider Trading and Trends

2015 was Nassim Usman's most active year for acquiring shares with 6 total transactions. Nassim Usman's most active month to acquire stocks was the month of July. 2024 was Nassim Usman's most active year for disposing of shares, totalling 10 transactions. Nassim Usman's most active month to dispose stocks was the month of April. 2024 saw Nassim Usman paying a total of $439,722.36 for 63,452 shares, this is the most they've acquired in one year. In 2024 Nassim Usman cashed out on 126,904 shares for a total of $992,214.81, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

GYRE THERAPEUTICS, INC. (GYRE) Snapshot price: $13.77

President & CEO

Nassim Usman owns 1,636 units of Common Stock which is worth $22,527.72. Nassim Usman used to own units in Series Y Preferred Stock but no longer holds any shares there. From 2015 to 2024 Nassim Usman acquired a total of 92,393 shares in GYRE THERAPEUTICS, INC. at a cost of $545,415.68, Nassim also disposed a total of 67,964.541 shares of GYRE THERAPEUTICS, INC. equalling to $992,214.81.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
$9.47
-$17,515.45
1.64K
Jun 28
Form 4
—
0
$10.53
-$143,977.00
1.64K
May 1
Form 4
—
0
$11.54
-$184,400.00
1.64K
Apr 1
Form 4
—
0
$12.10
-$206,600.00
1.64K
Mar 15
Form 4
—
0
—
—
0
Oct 31
Form 4
-100.00%
-34.16
—
—
0
Aug 31
Form 4
+15.26%
3.25K
$0.47
$1,527.50
24.54K
Aug 9
Form 4
+18.01%
3.25K
$0.46
$1,495.00
21.29K
Feb 9
Form 4
+5.05%
867
$3.62
$3,138.54
18.04K
Aug 9
Form 4/A
—
0
—
—
0
Feb 8
Form 4
+41.07%
5K
$4.63
$23,150.00
17.17K
Apr 5
Form 4
+5.02%
582
$4.81
$2,799.42
12.17K
Feb 9
Form 4
—
0
—
—
0
Feb 8
Form 4
+5.29%
582
$4.81
$2,799.42
11.59K
Aug 10
Form 4
+57.06%
4K
$3.91
$15,647.20
11.01K
Mar 13
Form 4
+6.53%
430
$6.23
$2,678.90
7.01K
Feb 10
Form 4
—
0
—
—
0
Jan 23
Form 4
+6.70%
413
$6.51
$2,688.63
6.58K
Aug 12
Form 4
+43.04%
4.4K
$4.63
$20,372.00
14.62K
May 20 - May 21
Form 4
+6.02%
350
$7.04
$2,464.00
6.17K
Feb 11
Form 4
+107.85%
5.73K
$4.63
$26,525.27
11.04K
Jan 31
Form 4
—
0
—
—
0
Jan 24
Form 4
—
0
—
—
0
Jul 30
Form 4
—
0
—
—
4.14K
Apr 9
Form 4
∞
88
$4.63
$407.44
88
Apr 4
Form 4
—
0
—
—
0
Jan 12
Form 4
—
0
—
—
0
Jul 11
Form 4/A
—
0
—
—
0
Jun 9
Form 4
—
0
—
—
0
Jun 9
Form 4
+5.38%
4K
$2.00
$8,000.00
78.38K
Dec 17
Form 4/A
—
0
—
—
0
Oct 22
Form 4
—
0
—
—
0
Oct 22
Form 4
+122.23%
74.38K
—
—
135.22K
Aug 20
Form 3
—
0
—
—
0
No matching records found

Principia Biopharma Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

SIRNA THERAPEUTICS INC No price found

Sr VP & Chief Op Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 22
Form 4
—
0
—
—
0
No matching records found